FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to haematology, and can be used in treating anaemia. Disclosed methods involve administering the compound of [[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid orally in a daily dose of 150 mg, 300 mg, 450 mg, 600 mg or 750 mg.
EFFECT: using the inventions makes it possible to increase the effectiveness of treating anaemia by increasing the haemoglobin level and the ability to bind iron, increasing haematopoiesis with no prolonged erythropoietin increase and preserving the level of hepcidin.
41 cl, 12 tbl, 9 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR INCREASING STABILISATION OF HYPOXYA INDUCED FACTOR-1 ALPHA | 2010 |
|
RU2521251C2 |
| APPLICATION OF STABILISERS OF HIF- ALPHA FOR INTENSIFICATION OF ERYTHROPOIESIS | 2004 |
|
RU2414214C2 |
| PROLYL HYDROXYLASE INHIBITORS | 2010 |
|
RU2518071C2 |
| COMPOSITIONS AND METHODS OF TREATING COLITIS | 2010 |
|
RU2518416C2 |
| PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
| PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
| PHARMACEUTICAL FORMULATIONS OF HIF HYDROXYLASE INHIBITORS | 2014 |
|
RU2681304C2 |
| CRYSTALLINE FORMS OF {[1-CYANO-5-(4-CHLOROPHENOXY)-4-HYDROXY-ISOQUINOLINE-3-CARBONYL]-AMINO}-ACETIC ACID | 2014 |
|
RU2666144C2 |
| TRIAZOLOPYRIDINE COMPOUND AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | 2010 |
|
RU2538963C2 |
| DRUG FOR TREATMENT OF ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE AND METHOD FOR ITS OBTAINING | 2020 |
|
RU2749719C1 |
